The company said the prescription drug will be available in “a limited number of stores” and “either in-person or via mail delivery in compliance with federal and state law.” It did not specify in which states mifepristone would be dispensed; two states ban its use after a few weeks of pregnancy and others are attempting to shirk access with new laws.
The FDA cleared a path for some retail pharmacies to dispense the drug in early January, but the allowance has a few requirements as pharmacies weigh political and financial considerations.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
